|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0013089,
umls-concept:C0055982,
umls-concept:C0162326,
umls-concept:C0205195,
umls-concept:C0205234,
umls-concept:C0246415,
umls-concept:C0876994,
umls-concept:C1516213,
umls-concept:C1522449,
umls-concept:C1522673
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-13
|
|
pubmed:abstractText |
Cardiac toxicity associated with anthracyclines and taxanes and/or radiotherapy (RT) can be life-threatening and can adversely affect quality of life. The aim was to evaluate treatment-related cardiac toxicity in breast cancer patients treated with doxorubicin/docetaxel/CMF sequential or combined regimens and RT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
116-21
|
|
pubmed:meshHeading |
pubmed-meshheading:19013659-Adult,
pubmed-meshheading:19013659-Aged,
pubmed-meshheading:19013659-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19013659-Breast Neoplasms,
pubmed-meshheading:19013659-Chi-Square Distribution,
pubmed-meshheading:19013659-Combined Modality Therapy,
pubmed-meshheading:19013659-Cyclophosphamide,
pubmed-meshheading:19013659-Doxorubicin,
pubmed-meshheading:19013659-Female,
pubmed-meshheading:19013659-Fluorouracil,
pubmed-meshheading:19013659-Heart Diseases,
pubmed-meshheading:19013659-Humans,
pubmed-meshheading:19013659-Methotrexate,
pubmed-meshheading:19013659-Middle Aged,
pubmed-meshheading:19013659-Neoplasm Staging,
pubmed-meshheading:19013659-Pilot Projects,
pubmed-meshheading:19013659-Prospective Studies,
pubmed-meshheading:19013659-Radiotherapy Dosage,
pubmed-meshheading:19013659-Taxoids,
pubmed-meshheading:19013659-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients.
|
|
pubmed:affiliation |
Radiotherapy Department, Institut Jules Bordet, Bruxelles, Belgium. nicolas.magne@igr.fr
|
|
pubmed:publicationType |
Journal Article
|
